Find the Right Market Report
Search thousands of industry reports, market insights, and research studies in one place.
Search thousands of industry reports, market insights, and research studies in one place.
Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
26 December 2025
Announcement Ipsen, a French-based biopharmaceutical company concentrating on marketing and drug development in neuroscience, rare disease and oncology spaces, has proudly revealed its exclusive lice...
26 December 2025
Announcement Cytokinetics received a green signal from the FDA for its cardiac myosin inhibitor, which has reserved the biotech to compete with Bristol Myers Squibb in the heart disease sector. This ...
24 December 2025
Announcement Tolmar, Inc. has proudly declared that its extended indication for Rubraca® has finally received the U.S. Food and Drug Administration (FDA) stamp. The extended indication allows its...
23 December 2025
Announcement Novo Nordisk has now registered a new drug application to receive the FDA’s approval stamp. This decision by Novo stems from its competition with Lilly in the weight loss market so...
23 December 2025
Announcement Avadel Pharmaceuticals plc, a leading biopharmaceutical company targeting transforming medicines to add value to the patient's quality of life, has declared its completion of the patient...
22 December 2025
Announcement The CDC has agreed to adopt the delayed Hepatitis B Vaccine Dose on the suggestion of its advisory committee. The advisory recommended that integrating these vaccine shots will be benefi...
19 December 2025
Announcement Takeda Strengthens Its Presence in Early-Stage Biotech Innovation Takeda Pharmaceutical has joined BaseLaunch, a venture creation and incubation platform focused on building early-stage...
18 December 2025
Announcement Immunome, Inc., a leading biotechnology company dedicated to establishing and introducing excellent, first-in-class, and best-in-class focused cancer therapies, has announced robust, pos...
17 December 2025
With the launch of trodinetide’s formulation, Neuren has achieved its second FDA approval: In December 2025, Neuren Pharmaceuticals announced a milestone achievement with the launch of trodinet...
16 December 2025
Announcement Mabylon AG is a known champion in the high-throughput discovery, establishment and engineering of human-inspired antibodies for the solution of inflammation, allergies and neurodegenera...
Speak with a healthcare analyst about your research, consulting, or platform needs.